Economic impact of community-acquired and nosocomial lower respiratory tract infections in young children in Germany

European Journal of Pediatrics

Volumn 164, Issue 10, 2005, Pages 607-615

  Ehlken, Birgit ^a   Ihorst, Gabriele ^b   Lippert, Barbara ^a   Rohwedder, Angela ^c   Petersen, Gudula ^d   Schumacher, Martin ^b   Forster, Johannes ^b  

^a MERG   (Germany)

^b UNIVERSITY OF FREIBURG   (Germany)

^c RUHR UNIVERSITY BOCHUM   (Germany)

^d St Joseph's Hospital Freiburg ^*

Author keywords

Cost of illness; Influenza viruses; Parainfluenza viruses; Respiratory syncytial viruses; Respiratory tract infection

Indexed keywords

ANALYTIC METHOD; ARTICLE; COMMUNITY ACQUIRED PNEUMONIA; CONTROLLED STUDY; COST BENEFIT ANALYSIS; DECISION MAKING; ECONOMIC ASPECT; EPIDEMIOLOGICAL DATA; FEMALE; GERMANY; HEALTH CARE COST; HOSPITAL INFECTION; HUMAN; INFANT; INFLUENZA VIRUS; INSURANCE; INTERVIEW; MAJOR CLINICAL STUDY; MALE; MEDICAL RECORD; MEDICAL SERVICE; NEWBORN; PARAINFLUENZA VIRUS; PRESCHOOL CHILD; PRIORITY JOURNAL; RESPIRATORY SYNCYTIAL PNEUMOVIRUS; RESPIRATORY TRACT INFECTION; TELEPHONE;

AGE DISTRIBUTION; AMBULATORY CARE; CHILD, PRESCHOOL; COMMUNITY-ACQUIRED INFECTIONS; COST OF ILLNESS; CROSS INFECTION; FEMALE; GERMANY; HEALTH CARE COSTS; HOSPITALIZATION; HUMANS; INFANT; INFANT, NEWBORN; INSURANCE, HEALTH, REIMBURSEMENT; MALE; ORTHOMYXOVIRIDAE INFECTIONS; PARAMYXOVIRIDAE INFECTIONS; PROSPECTIVE STUDIES; RESPIRATORY SYNCYTIAL VIRUS INFECTIONS; RESPIRATORY TRACT INFECTIONS;

EID: 26444509795     PISSN: 03406199     EISSN: None     Source Type: Journal    
DOI: 10.1007/s00431-005-1705-0     Document Type: Article

References (30)

1. Anderson LJ, Hendry RM, Pierik LT, Tsou C, McIntosh K (1991) Multicenter study of strains of respiratory syncytial virus. J Infect Dis 163:687-692
2. Behrendt CE, Decker MD, Burch DJ, Watson PH (1998) International variation in the management of infants hospitalized with respiratory syncytial virus. International RSV Study Group. Eur J Pediatr 157:215-220
3. Cunningham CK, McMillan JA, Gross SJ (1991) Rehospitalization for respiratory illness in infants of less than 32 weeks' gestation. Pediatrics 88:527-532
4. Deshpande SA, Northern V (2003) The clinical and health economic burden of respiratory syncytial virus disease among children under 2 years of age in a defined geographical area. Arch Dis Child 88:1065-1069
5. Einheitlicher Bewertungsmaßstab (EBM) (2001) Köln: Deutscher Ärzte
6. Forster J, Ihorst G, Rieger CH, Stephan V, Frank HD, Gurth H, Berner R, Rohwedder A, Werchau H, Schumacher M, Tsai T, Petersen G (2004) Prospective population-based study of viral lower respiratory tract infections in children under three years (the PRI.DE study). Eur J Pediatr 163:709-716
7. Glezen WP, Taber LH, Frank AL, Kasel JA (1986) Risk of primary infection and reinfection with respiratory syncytial virus. Am J Dis Child 140:543-546
8. Greenough A, Cox S, Alexander J, Lenney W, Turnbull F, Burgess S, Chetcuti PA, Shaw NJ, Woods A, Boorman J, Coles S, Turner J (2001) Health care utilization of infants with chronic lung disease, related to hospitalization for RSV infection. Arch Dis Child 85:463-468
9. Groothuis JR, Gutierrez KM, Lauer BA (1988) Respiratory syncytial virus infection in children with bronchopulmonary dysplasia. Pediatrics 82:199-203
10. Hall CB (2000) Respiratory syncytial virus. In: Mandell GL, Dolln R (eds) Principles and practice of infectious diseases. Churchill Livingstone, New York, pp 1782-1801
11. Hannoveraner Konsens Gruppe (1999) Dt. Empfehlungen zur gesundheits-ökonomischen Evaluation - Revidierte Fassung des Hannoveraner Konsens. Gesundheitsökonomie & Qualitätsmanagement 4:A62-A65
12. Ihorst G, Forster J, Petersen G, Schumacher M (2004) Determination of the population size in an epidemiological study with children. Methods Inf Med 5:479-482
13. Marchetti A, Lau H, Magar R, Wang L, Devercelli G (1999) Impact of palivizumab on expected costs of respiratory syncytial virus infection in preterm infants: potential for savings. Clin Ther 21:752-766
14. Miedema CJ, Kors AW, Tjon A, Ten WE, Kimpen JL (2001) Medical consumption and socioeconomic effects of infection with respiratory syncytial virus in The Netherlands. Pediatr Infect Dis J 20:160-163
15. Neuzil KM, Mellen BG, Wright PF, Mitchel EF, Griffin MR (2000) The effect of influenza on hospitalizations, outpatient visits, and courses of antibiotics in children. N Eng J Med 342:225-231
16. Reed G, Jewett PH, Thompson J, Tollefson S, Wright PF (1997) Epidemiology and clinical impact of parainfluenza virus infections in otherwise healthy infants and young children < 5 years old. JID 175:807-813
17. Rietveld E, De Jonge HC, Polder JJ, Vergouwe Y, Veeze HJ, Moll HA, Steyerberg EW (2004) Anticipated costs of hospitalization for repiratory syncytial virus infection in young children at risk. Pediatr Infect Dis J 23:523-529
18. Roeckl-Wiedmann I, Liese JG, Grill E, Fischer B, Carr D, Beloradsky BH (2003) Economic evaluation of possible prevention of RSV-related hospitalizations in premature infants in Germany. Eur J Pediatr 162:237-244
19. Rote Liste (2002) Arzneimittelverzeichnis des BPI und VFA. Bundesverband der Pharmazeutischen Industrie e.V.. Frankfurt, Aulendorf: Editio Cantor
20. Scuffham PA, West PA (2002) Economic evaluation of strategies for the control and management of influenza in Europe. Vaccine 20:2562-2578
21. Statistisches Bundesamt (2001) Statistisches Jahrbuch 2001 für die Bundesrepublik Deutschland. Wiesbaden: Metzler-Poeschel
22. Statistisches Bundesamt (2002) Statistisches Jahrbuch 2002 für die Bundesrepublik Deutschland. Wiesbaden: Metzler-Poeschel
23. Stevens TP, Sinkin RA, Hall CB, Maniscalco WM, McConnochie KM (2000) Respiratory syncytial virus and premature infants born at 32 weeks' gestation or earlier: hospitalization and economic implications of prophylaxis. Arch Pediatr Adolesc Med 154:55-61
24. Szucs T, Behrens M, Volmer T (2001) [Public health costs of influenza in Germany 1996- a cost-of-illness analysis]. Med Klin (Munich) 96:63-70
25. The IMPACT-RSV Study Group (1998) Palivizumab, a humanized respiratory syncytial virus monoclonal antibody, reduces hospitalization from respiratory syncytial virus infection in high-risk infants. Pediatrics 102:531-537
26. The PREVENT Study Group (1997) Reduction of respiratory syncytial virus hospitalization among premature infants and infants with bronchopulmonary dysplasia using respiratory syncytial virus immune globulin prophylaxis. Pediatrics 99:93-99
27. Weigl JA, Puppe W, Schmitt HJ (2004) Variables explaining the duration of hospitalization in children under two years of age admitted with acute airway infections: does respiratory syncytial virus have a direct impact? Klin Pädiatr 216:7-15
28. Weigl JA, Puppe W, Schmitt HJ (2002) The incidence of influenza-associated hospitalizations in children in Germany. Epidemiol Infect 129:525-533
29. Weigl JA, Puppe W, Rockahr S, Schmitt HJ (2002) Burden of disease in hospitalized RSV-positive children in Germany. Klin Padiatr 214:334-342
30. Zahlenbericht der Privaten Krankenversicherer (2001/2002), Köln. www.pkv.de